Tumourigenesis within the intestine is potently driven by deregulation of the Wnt pathway. a process epigenetically regulated by the chromatin remodelling factor Brg1. We aimed to investigate this interdependency in an in vivo setting and assess the viability of Brg1 as a potential therapeutic target. Using a range of transgenic approaches. https://www.ngetikin.com/